CLS B — Clinical Laserthermia Systems AB Share News
0.000.00%
Last trade - 00:00- SEK90.69m
- SEK83.48m
- SEK17.49m
Brief: Clinical Laserthermia Systems Announces Collaboration With NIH CC
Brief: Clinical Laserthermia Gets Around SEK 12.8 Mln Through Warrant Exercise
Brief: Clinical Laserthermia Systems, Soteria Medical Enter Strategic Partnership
Brief: Clinical Laserthermia Carries Out Directed Issue Of Shares
Brief: Clinical Laserthermia Systems 9-Mth Net Sales At SEK 2 Mln
Brief: Clinical Laserthermia Systems Carries Out Directed Issue Of Shares
Brief: Clinical Laserthermia Systems Receives SEK 5.5 Million Order
ClearPoint Neuro up on FDA clearance for partner's laser therapy system
Brief: Clearpoint Neuro Announces FDA Clearance For Clearpoint Prism Neuro Laser Therapy System
Brief: Clinical Laserthermia Systems: Outcome Of Rights Issue Of Units
Brief: CLS Shareholder Khattar Subscribes For B-Shares In Rights Issue
Brief: Clinical Laserthermia Systems Appoints New CFO
Brief: Clinical Laserthermia Systems Q2 Loss After Financial Items Narrows To SEK 17 Mln
Brief: Clinical Laserthermia Systems Says Board Resolves On Rights Issue Of Units For Initial Amount Of About 69.3 Msek
Brief: Clinical Laserthermia Systems Q1 Pre-Tax Loss Widens To SEK 13.8 Mln
Brief: CLS Appoints Dan J. Mogren As Permanent CEO
Brief: Clinical Laserthermia Systems Enters Agreement With Quadia Diagnostic Imaging Center
Brief: Clinical Laserthermia Systems Acting CEO Returns To Work
Brief: CLS Granted Patent In China For Product And Method Of Controlling Treatment With imILT Protocol